tiprankstipranks
Pacific Biosciences Updates Executive Severance Agreements
Company Announcements

Pacific Biosciences Updates Executive Severance Agreements

Story Highlights

Pick the best stocks and maximize your portfolio:

Pacific Biosciences ( (PACB) ) has provided an update.

Pacific Biosciences announced amendments to the change in control and severance agreements for its CEO, Christian O. Henry, and COO, Mark Van Oene. These changes include lump sum severance payments and an extension of the change of control period, reflecting the company’s commitment to secure executive leadership stability amid potential transitions.

More about Pacific Biosciences

Pacific Biosciences of California, Inc. operates in the biotechnology industry, focusing on providing advanced sequencing technologies and solutions to support scientific research and clinical applications.

YTD Price Performance: -79.15%

Average Trading Volume: 9,696,472

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $560.1M

Learn more about PACB stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPacific Biosciences Appoints CEO as Interim CFO
TheFlyCathie Wood’s ARK Investment buys 289K shares of PacBio today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App